Our firm acted as Swiss legal counsel to Biosynth Group Limited on the acquisition of VIO Chemicals AG.
Biosynth Group Limited, a portfolio firm of KKR, acquired a majority stake in VIO Chemicals AG, a Swiss based company.Biosynth is a supplier of critical materials, securing life science supply chains with global research, manufacturing, and distribution facilities. Biosynth is owned amongst others by KKR, Ampersand Capital Partners and its management.
VIO Chemicals is a Swiss based company specialized in the custom design and production of specialty chemicals, intermediates and Active Pharmaceutical Ingredients (APIs).
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.